Therapeutic augmentation of ketogenic diet with a sodium-glucose cotransporter 2 inhibitor in a super-refractory status epilepticus patient.

Blunck, Joseph R; Newman, Joseph W; Fields, Ronald K; Croom, John E

Blunck, Joseph R; Newman, Joseph W; Fields, Ronald K; Croom, John E.

Afiliação

Blunck JR; Saint Luke's Hospital, 4401 Wornall Rd., 64111 Kansas City, MO, United States of America.
Newman JW; Saint Luke's Hospital, 4401 Wornall Rd., 64111 Kansas City, MO, United States of America.
Fields RK; Saint Luke's Hospital, 4401 Wornall Rd., 64111 Kansas City, MO, United States of America.
Croom JE; Saint Luke's Hospital, 4401 Wornall Rd., 64111 Kansas City, MO, United States of America.

Epilepsy Behav Case Rep ; 10: 61-64, 2018.

Article em En | MEDLINE | ID: mdl-30073144

Palavras-chave

Epilepsy; Ketoacidosis; Ketogenic diet; Ketosis; Pentobarbital; Refractory status epilepticus; Seizure; Sodium-glucose cotransporter 2 inhibitor; Status epilepticus; Super-refractory status epilepticus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article